PharmaVoice 29. Apr. 2026 Revolution’s on a pancreatic cancer winning streak. What comes next for the biotech?
PharmaVoice 28. Apr. 2026 Why AI maker Anthropic’s deal with Coefficient Bio could be a pharma turning point